CMRX - Chimerix, Inc.

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
33,056
33,824
1,979
5,372
12,519
Cost of revenue
447
447
-
-
-
Gross profit
33,377
33,377
-
-
-
Operating expenses
Research development
86,687
71,631
73,817
36,232
42,288
Selling general and administrative
22,026
22,132
18,672
13,656
21,169
Total operating expenses
108,713
93,763
92,489
49,888
63,457
Operating income or loss
-76,104
-60,386
-90,510
-44,516
-50,938
Total other income/expenses net
229,670
229,670
-82,890
-
-65,045
Income before tax
153,782
172,203
-173,236
-43,522
-112,576
Income tax expense
36
36
-
-
-
Income from continuing operations
153,629
172,167
-173,236
-43,522
-112,576
Net income
153,629
172,167
-173,236
-43,522
-112,576
Net income available to common shareholders
153,629
172,167
-173,236
-43,522
-112,576
Basic EPS
-
1.97
-2.04
-0.70
-2.03
Diluted EPS
-
1.94
-2.04
-0.70
-2.03
Basic average shares
-
87,555
84,930
62,184
55,502
Diluted average shares
-
88,776
84,930
62,184
55,502
EBITDA
-
-60,386
-90,510
-44,516
-50,938